Mika Scheinin
 MD, PhD, Professor Emeritus

  

  

  

22 of 25

  

  

  

---

• Oral bioavailability of ospemifene improves with food intake  (2013)  
  • International Journal of Clinical Pharmacology and Therapeutics
   Koskimies P, Katila K, Lammintausta R, Aaltonen AM, Vuorinen J, Saarni O, Scheinin M

  
  

• Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine  (2013)  
  • Veterinary Anaesthesia and Analgesia
   Vainionpaa MH, Raekallio MR, Pakkanen SAE, Ranta-Panula V, Rinne VM, Scheinin M, Vainio OM

  
  

• Rifampicin markedly decreases the exposure to oral and intravenous tramadol  (2013)  
  • European Journal of Clinical Pharmacology
   Saarikoski T, Saari TI, Hagelberg NM, Neuvonen M, Neuvonen PJ, Scheinin M, Olkkola KT, Laine K

  
  

• Single-dose and steady-state pharmacokinetics of ospemifene, a selective estrogen receptor modulator, in postmenopausal women  (2013)  
  • International Journal of Clinical Pharmacology and Therapeutics
   Koskimies P, Turunen J, Lammintausta R, Scheinin M

  
  

• Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction  (2013)  
  • European Journal of Clinical Pharmacology
   Hagelberg NM, Saarikoski T, Saari TI, Neuvonen M, Neuvonen PJ, Turpeinen M, Scheinin M, Laine K, Olkkola KT

  
  

• Tietoruutu L2 – Lääkeaineiden sitoutuminen reseptoriin  (2013)  Farmakologia ja toksikologia Scheinin M

  
  

• Variation in the alpha(2A) adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose  (2013)  
  • Pharmacogenetics and Genomics
   Ghimire LV, Muszkat M, Sofowora GG, Scheinin M, Wood AJJ, Stein CM, Kurnik D

  
  

• Adrenoseptoriagonistit (sympatomimeetit)  (2012)  Farmakologia ja toksikologia Scheinin Mika

  
  

• Clinical research and clinical trials in the Region of South‐West Finland  (2012)   Scheinin Mika

  
  

• CYP2A6 genetic variation and dexmedetomidine disposition.  (2012)  
  • European Journal of Clinical Pharmacology
   Kohli Utkarsh, Pandharipande Pratik, Muszkat Mordechai, Soforowa Gbenga G, Friedman Eitan A, Scheinin Mika, Wood Alastair J J, Ely E Wesley, Tyndale Rachel F, Choi Leena, Stein C Michael, Kurnik Daniel